Short answer: To add lab testing to telehealth, you partner with CLIA-certified labs, choose how patients give samples (at-home phlebotomy, in-person draws at patient service centers or at-home collection kits), decide whether tests are provider-ordered or patient-initiated elective panels, and build a workflow where a licensed provider reviews results. State rules on direct access testing vary, so confirm each state before launch.
Labs turn a telehealth brand into a real digital clinic. When you add lab testing to telehealth, providers get objective information to review, patients get a clearer picture of their own health data, and your programs can include baseline and follow-up testing where a provider decides it is appropriate. Many hormone, weight management and longevity programs are built around labs from day one.
This guide covers the founder-level basics: how CLIA works, provider-ordered vs patient-initiated labs, state rules on direct to consumer lab testing, phlebotomy vs at-home kits, how results review should work, and where wearables fit. For the platform view, see our page on telehealth lab testing and wearables.
Why add lab testing to telehealth?
- Better information for providers. Many treatment decisions, such as hormone therapy, depend on labs the provider orders or reviews.
- Monitoring over time. Some programs call for follow-up labs at intervals the provider sets.
- A more complete patient experience. Results that appear in the patient’s branded app keep care inside your brand.
- New program types. Elective lab panels, such as metabolic or thyroid panels, can be offered where state law allows.
CLIA basics for telehealth founders
The Clinical Laboratory Improvement Amendments of 1988 (CLIA) set federal quality standards for laboratory testing performed on human specimens in the United States. According to the Centers for Medicare & Medicaid Services (CMS), which runs the program with FDA and CDC, CLIA standards are designed to make test results accurate, reliable and timely. Requirements are tiered by test complexity, so more complex testing carries stricter standards.
CLIA certificate types include:
- Certificate of Waiver for sites performing only simple waived tests
- Certificate for Provider-Performed Microscopy Procedures for certain microscopy tests performed by providers
- Certificate of Registration, issued while a lab awaits its compliance survey
- Certificate of Compliance for labs surveyed by the state agency
- Certificate of Accreditation for labs accredited by a CMS-approved accreditation organization
What this means for you: in most telehealth models, your brand is not performing the testing. Your lab partners are, and each one should hold the appropriate CLIA certificate for the tests it runs. Ask every lab partner for its CLIA number and any state lab licenses, and have a healthcare attorney confirm whether your own model needs anything more. Some states also license laboratories separately.
Provider-ordered vs patient-initiated labs
There are two main ways telehealth lab testing happens, and many brands use both.
| Factor | Provider-ordered labs | Patient-initiated (elective) labs |
|---|---|---|
| Who starts it | A licensed provider orders tests as part of evaluation or monitoring | The patient chooses and buys a panel, such as metabolic or thyroid |
| Order authorization | The treating provider | A licensed provider authorizes the order behind the scenes |
| Typical use | Baseline labs before treatment, follow-up monitoring | Direct to consumer lab testing and wellness panels |
| State availability | Broad, subject to provider licensure | Varies by state, and some states restrict it |
| Results follow-up | Reviewed by the ordering provider as part of care | Needs a clear plan for review, abnormal results and next steps |
Elective lab panels
Elective lab panels let patients buy tests on their own initiative. A licensed provider still authorizes each order, and availability varies by state. Elective panels can be a natural first step into a program, since a patient who has results may then want a provider evaluation. Keep the offer honest: describe what the panel measures, not what it will reveal or fix.
State rules on direct to consumer lab testing
Direct access testing, where a consumer orders a lab test without first seeing a provider, is regulated by the states. Rules range from broadly permitted, to permitted with limits on certain tests, to heavily restricted. At the time of writing, sources that track these rules commonly list New York, New Jersey and Rhode Island among the most restrictive states, and other states limit specific tests or require a provider’s order for them. Laws change, so treat any list as a starting point and have counsel confirm each state you plan to serve.
How to handle state variation:
- Gate by state. Your platform should check the patient’s state before showing elective panels.
- Offer a provider-ordered path. In restricted states, route patients to a provider evaluation first.
- Check the lab partner’s rules. Labs have their own state restrictions and test menus.
- Recheck regularly. Add direct access testing rules to your compliance calendar and to your telehealth compliance checklist.
At-home lab testing for telehealth: phlebotomy vs kits vs service centers
How a patient gives a sample affects convenience, the tests available and your operations.
| Collection method | How it works | Strengths | Considerations |
|---|---|---|---|
| In-person draw at a patient service center | Patient visits a lab location, such as a Quest or Labcorp site, for a venous draw | Wide test menus, broad coverage in many areas | Patient has to travel and may wait |
| At-home phlebotomy | A trained phlebotomist visits the patient’s home | Very convenient, full venous draw | Coverage varies by area, scheduling required |
| At-home collection kit | Patient collects a sample, such as a finger-prick or saliva sample, and mails it to the lab | No appointment, shipped to the door | Not every test is available by kit, and sample quality depends on correct collection |
Most brands offer more than one option, so patients can choose what fits and so coverage gaps in one method are filled by another. Ask lab partners which tests are validated for each collection method, and give patients clear instructions, including any fasting or timing requirements the provider sets.
Building the results review workflow
Results are where lab programs succeed or fail. Before you launch, decide exactly who sees what, when and what happens next.
- Results arrive in one chart. Lab results should flow directly into the patient record the provider uses, not into email or a separate portal.
- Provider review. A licensed provider reviews results for provider-ordered labs, and your protocol should define how elective results are reviewed.
- Abnormal and critical results. Define how the lab flags critical values, who is contacted, how fast and what the patient is told. Critical results need a real process with a person on the other end.
- Patient communication. Results should appear in the patient’s branded app with plain-language context and a clear way to ask questions.
- Clinical next steps. The provider decides whether treatment is appropriate, whether more testing is needed, or whether the patient should see a local provider or seek urgent care.
- Documentation. Every review, message and decision is recorded in the chart.
Remember that lab data is protected health information. Every vendor that handles it should sign a business associate agreement. Our guide on what makes a telehealth platform HIPAA compliant covers the safeguards.
Adding wearables and health devices
Labs give providers a snapshot. Wearables and connected devices can add ongoing data between visits. Patients can connect smart rings, smartwatches, continuous glucose monitors, blood pressure cuffs and smart scales, and many devices sync through phone health hubs such as Apple Health and Google Health Connect.
Use device data thoughtfully:
- Collect what providers will actually review. More data is not better if no one looks at it.
- Set expectations. Tell patients device data is not monitored in real time unless it truly is, and that emergencies go to 911.
- Keep it in one chart. Device data belongs next to labs and intake, not in a separate tool.
- Avoid diagnostic claims. Do not market consumer wearables as diagnosing or treating conditions.
See telehealth lab testing and wearables for how labs and device data come together on WellieMD.
How to add lab testing to telehealth: step by step
- Decide the role of labs in each program. Baseline, monitoring, elective panels or all three.
- Get legal guidance. A healthcare attorney should review CLIA, state lab licensing, direct access testing rules and your ordering model.
- Choose lab partners and collection methods. Confirm CLIA certificates, test menus, state coverage and collection options.
- Build ordering into intake. Route patients to the right tests based on program, state and provider decision.
- Define the results protocol. Review responsibility, turnaround targets, critical value handling and patient messaging.
- Connect results to the chart and the app. Providers and patients should see results in one place.
- Write compliant copy. Describe what tests measure. Do not promise diagnoses, outcomes or peace of mind.
- Test end to end. Place test orders, confirm results flow correctly and rehearse the critical result process before launch.
For hormone programs, labs are often part of provider evaluation. See how to start a TRT digital clinic and how to start a perimenopause and menopause telehealth clinic.
Common mistakes to avoid
- Selling panels without a review plan. Results without follow-up leave patients confused and create risk.
- Ignoring state rules. Direct access testing is not allowed the same way everywhere.
- Overpromising. Tests measure markers. They do not guarantee answers or results.
- Scattered data. Results in email or PDFs are hard to review and hard to protect.
- Skipping the critical result drill. Rehearse it before your first patient.
How WellieMD helps
WellieMD is a white-label telehealth platform with labs built in. It connects to 15,000+ lab tests across 20+ lab partners, including Quest and Labcorp plus specialty labs, with at-home phlebotomy, in-person draws at patient service centers and at-home collection kits. It supports elective labs, where patients can buy panels themselves and a licensed provider authorizes the order, with availability varying by state. Patients can connect 300+ health devices through phone health hubs, with 33 direct device integrations, and results flow into one chart for providers and into the patient’s branded app. Branded intake, a licensed provider network, licensed 503A pharmacy routing, payments, subscriptions, refills and HIPAA safeguards with a BAA are part of the same platform. If you are planning a lab program, book a demo and we will build it with you.
Frequently asked questions
Do I need a CLIA certificate to add lab testing to telehealth?
In most telehealth models, your lab partners perform the testing and hold the CLIA certificates. Your brand usually does not run a lab itself. Confirm your specific model, and any state lab licensing, with a healthcare attorney.
Can patients order their own lab tests?
In many states, yes, through elective or direct to consumer lab testing, with a licensed provider authorizing the order. Some states restrict direct access testing, and rules vary by test. Gate elective panels by state and confirm current law.
What is the difference between at-home phlebotomy and an at-home kit?
At-home phlebotomy sends a trained professional to the patient’s home for a venous draw. An at-home collection kit lets the patient collect a sample, such as a finger-prick, and mail it to the lab. Kits are convenient, but not every test is available by kit.
Who reviews telehealth lab results?
For provider-ordered labs, the ordering licensed provider reviews results as part of care. For elective panels, your protocol should define review, abnormal result follow-up and patient communication. Critical results need a defined, fast process.
Can wearable data be used in a digital clinic?
Yes. Patients can connect devices such as smart rings, smartwatches, CGMs, blood pressure cuffs and smart scales, and the data can flow into the provider’s chart. Set clear expectations about how often data is reviewed, and never market consumer devices as diagnostic.
This guide is general information, not legal or medical advice. Lab testing rules vary by state and change over time, so confirm requirements with a healthcare attorney. Clinical decisions are made by licensed providers.